The Cross-Party Group (CPG) on Brain Tumours held its Annual General Meeting (AGM), on Monday 31ˢᵗ March, reaffirming its commitment to advancing research, diagnosis and treatment for brain tumour patients in Scotland.
Convener Beatrice Wishart MSP welcomed everyone to the meeting and sought approval for the previous meeting's minutes. Ms Wishart (pictured above, on the right, with Jackie Baillie MSP, who was also present at the meeting) was re-elected as Convener for another year, with Brain Tumour Research providing the secretariat. Deputy Convener Colin Smyth MSP commended Brain Tumour Research for organising excellent meetings since the Group’s inception.
The CPG on Brain Tumours serves as a collaborative platform, bringing together Members of the Scottish Parliament, researchers, clinicians, patients, charities and advocacy groups to address the challenges faced by the brain tumour community. The group’s objectives include increasing awareness, promoting early diagnosis, and advocating for enhanced research funding to improve patient outcomes.
In previous sessions, the CPG has highlighted critical issues, such as the need for better access to advanced treatments like Proton Beam Therapy. Experts, including Professor Anthony Chalmers from the University of Glasgow, have emphasised the importance of increased investment in research to develop more effective therapies.
Reflecting on the AGM and the ongoing work of the CPG, our Policy and Public Affairs Manager Thomas Brayford, stated, “The AGM caps off a very busy March for Brain Tumour Research. We look forward to another impactful year with the CPG, having built a strong platform for meaningful change in Scotland."
Related reading: